Description

Benz[F]Isoquinoline, 1,2,3,4,4A,10B-Hexahydro-3,6-Dimethyl-, trans- (9Ci) is a complex, stereochemically defined heterocyclic compound that serves as a valuable synthetic intermediate and research chemical. Its rigid, fused-ring structure makes it a key building block for the development of novel pharmaceuticals and advanced materials. This compound is primarily sought by research chemists and process development scientists in the pharmaceutical, agrochemical, and specialty chemical industries for creating new molecular entities with targeted biological or physical properties.

Application

• Pharmaceutical Intermediate: Serves as a core scaffold or precursor in the synthesis of potential drug candidates, particularly for central nervous system (CNS) targets or anti-infective agents.
• Agrochemical Research: Used in the development of new herbicides, fungicides, or insecticides, leveraging its complex heterocyclic structure for novel modes of action.
• Ligand Synthesis: Acts as a precursor for creating sophisticated chiral ligands used in asymmetric catalysis for the production of enantiomerically pure compounds.
• Material Science Research: Investigated as a building block for organic semiconductors, liquid crystals, or fluorescent dyes due to its fused aromatic system.
• Academic & R&D: Utilized in university and corporate research laboratories for methodological studies in organic synthesis and heterocyclic chemistry.
• Chemical Reference Standard: Supplied as a high-purity standard for analytical method development, quality control, and regulatory submissions.

Basic Information

Product Name	Benz[F]Isoquinoline, 1,2,3,4,4A,10B-Hexahydro-3,6-Dimethyl-, trans- (9Ci)
CAS No.	780701-93-1
Molecular Formula	C15H19N
Molecular Weight	213.32 g/mol
Synonyms	trans-1,2,3,4,4a,10b-Hexahydro-3,6-dimethylbenz[f]isoquinoline; 3,6-Dimethyl-1,2,3,4,4a,10b-hexahydrobenz[f]isoquinoline, trans-; Benz[f]isoquinoline, 1,2,3,4,4a,10b-hexahydro-3,6-dimethyl-, trans-; trans-3,6-Dimethyl-1,2,3,4,4a,10b-hexahydrobenz[f]isoquinoline; 780701-93-1; BRN 8230995
EINECS	Contact for details

Quality Control

Our Benz[F]Isoquinoline derivative is produced under strict quality management protocols. Each batch undergoes comprehensive analytical characterization using techniques including HPLC, GC, NMR, and mass spectrometry to confirm identity, isomeric purity (trans- configuration), and chemical purity. Certificates of Analysis (COA) detailing all test results are provided and available upon request, ensuring full traceability and compliance with your research or development specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to minimize exposure to moisture and air.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Isomeric Purity (trans-)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.